类风湿关节炎B细胞活化因子受体表达的调节

niwanmao

Exp Mol Med. 2011 June 30; 43(6): 350–357.
Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells

Yun-Ju Woo,1,* Bo-Young Yoon,2,* Joo-Yeon Jhun,1 Hye-Jwa Oh,1 Sewon Min,3 Mi-La Cho,1 Sung-Hwan Park,1 Ho-Youn Kim,1 and Jun-Ki Min1

Abstract
B cells play an important role in the pathogenesis of rheumatoid arthritis (RA). High levels of B cell activating factor (BAFF) are detected in autoimmune diseases. BAFF and BAFF receptor (BAFF-R) are expressed in B and T cells of RA synovium. The study was undertaken to identify the NF-κB signal pathway involved in the induction of BAFF-R in human B cells. Immunohistochemical staining of NF-κB p65, NF-κB p50, BAFF, and BAFF-R was performed on sections of synovium from severe and mild RA and osteoarthritis (OA) patients. Peripheral blood mononuclear cells (PBMCs) were isolated from control and RA patients and B cells were isolated from controls. BAFF-R was analyzed by flow cytometry, realtime PCR and confocal staining after treatment with NF-κB inhibitors. NF-κB p65, NF-κB p50, BAFF, and BAFF-R were highly expressed in severe RA synovium relative to mild RA synovium or OA synovium. BAFF-R expression was reduced by NF-κB inhibitors in PBMCs and B cells from normal controls. We also showed reduction in expression of BAFF-R via inhibition of the NF-κB pathway in PBMCs of RA patients. BAFF/BAFF-R signaling is an important mechanism of pathogenesis in RA and that BAFF-R reduction by NF-κB blocking therapy is another choice for controlling B cells in autoimmune diseases such as RA.

Keywords: B-cell activation factor receptor, B-cell activating factor, B-lymphocytes, NF-κB, rheumatoid arthritis


全文下载：http://www.ncbi.nlm.nih.gov/pmc/ ... /pdf/emm-43-350.pdf
专家评论见下图：

专家评论

huzengwu

有了这篇，全文就齐了